Peer Review History
| Original SubmissionMarch 2, 2020 |
|---|
|
PONE-D-20-06115 Mapping breast and cervical cancer awareness in Uganda and South Africa PLOS ONE Dear Prof Moodley, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. We would appreciate receiving your revised manuscript by Jun 20 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Joel Msafiri Francis, MD, MS, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Mapping Breast and Cervical awareness in Uganda and South Africa. 1. This is a very good paper; however, I find it so ‘bulky’ to be one paper. Breast cancer awareness alone would be a good paper and so would cervical cancer awareness. In the future, consider splitting these as two separate papers. 2. The comparison between South Africa and Uganda is a good one, a low and middle-income country study is a bonus. It brings out unique findings. 3. Please mention which particular districts or region where your study was conducted in Uganda and South Africa. You mention that participants spoke Acholi and KiXhosa, but not the study location. 4. What was the recall period for the risk factors? Where did they know most about the risk factors? If this 5. I wonder why the authors chose to use chi square tests and not do further regression analysis to determine which the strongest predictors of awareness are. Chi square tests show that there is an association but it is important to show the strength of association and eliminate confounders Reviewer #2: The manuscript titled Mapping breast and cervical cancer awareness in Uganda and South Africa aim to measure breast cancer and cervical cancer symptom and risk factor awareness and recognition and lay beliefs among urban and rural population in South African and Uganda. This is an important study, particularly in the context of the high breast and cervical burden in SSA where community awareness has not been assessed. However, I have concerns regarding the readability of the manuscript. The title does not incorporate what is being assessed in the study. It doesn’t specify that breast and cervical cancer risk factor and symptom awareness and lay beliefs are being measured and associated socio-demographic factors assessed. Study outcomes are not well defined. There is limited description of how scores were organised and assessed for the analysis in the materials and methods, making it difficult to interpret results specifically for the multivariate analysis. Additionally, results are not well presented making it difficult to understand whether as a reviewer or as a reader. I am also concerned that not all results, most importantly multivariable results, are presented in tables included in the manuscript. The sample selection diagram to be revised and highlight/denote whether a household represents an individual. Additionally, the reported number of households assessed in text does not match with what is reported in the diagram. The discussion needs to be considerably strengthened. Authors should try limiting repetition of results and focus more on discussing what the findings mean and relating it back to the aim of the study, how results compare to findings from previous studies or results from national programs and providing key recommendations. There are several grammatical errors that the authors should correct. The authors should also cite appropriately in text and references should follow journal format. Overall, substantial revisions are required before the manuscript can be published. The authors need to be clear what the main aim of this study is and be concise about documenting study methods, reporting results and discussing the results. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: JULIET NABIRYE Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-20-06115R1 Mapping awareness of breast and cervical cancer risk factors, symptoms and lay beliefs in Uganda and South Africa PLOS ONE Dear Dr. Moodley, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Sep 28 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Joel Msafiri Francis, MD, MS, PhD Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #3: All comments have been addressed Reviewer #4: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #3: Partly Reviewer #4: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #3: Yes Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #3: Yes Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #3: Yes Reviewer #4: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #3: Dear Author This is a very good attempt to map the awareness level of two countries in relation to two important cancers among women. Content of this manuscript is very general and there is no new things to understand or practice. Your work is very lengthy and it is very difficult to read and understand this manuscript with so much content with many tables. I appreciate your efforts but thee is nothing to learn from this scientific piece. I took many hours to read it and understand before reaching to a conclusion. Reviewer #4: The amount of results presented is too much and appears to be beyond the scope of a single manuscript. While the authors have made sincere efforts to bring all the content in one manuscript, the number of variables(awareness of risk factors, symptoms and beliefs for two cancers) studied and the number of settings compared(urban and rural areas of two countries) makes it complicated. It would be worth seriously considering to split the manuscript into two in order to give justice to the amount of efforts and resources invested. 68, 69 – The conclusion statement is too generic. The same words can be written for almost any descriptive study. It needs to be made a bit more specific. 114-115 - “We conducted a community-based cross-sectional survey of women aged 18 years and older in one urban and one rural site in Uganda and SA (total of 4 sites).” How were the sites selected and how much were they representative of the respective countries in terms of socio-economic and demographic variables. Also a brief description of the two countries in terms of number of states, population, etc. may help. The paper seems to generalize the findings for the two countries respectively from the study, which may not be possible if there are widespread differences across different states within each country. 174 -175 - “We used the same open and closed questions to measure recall and recognition of cervical cancer risk factors (11 items) and symptoms (11 items)” - the meaning conveyed from this line is not clear. One of the limitation in the discussion states that the questions for recall and recognition were asked differently. 206-207 - “Medians and interquartile ranges (IQR) are reported for continuous variables.” - to be written in past tense Tables 2,3,4 and 5 – Please mention the test in the footnotes. Based on my interpretation from the description, the places where z value is reported is meant for the Man Whitney U test. Those who have not heard of breast cancer should not be included in symptom identification as the awareness about the symptom if the person is not aware about the disease becomes irrelevant. In methodology there is mention of only prompted questions on lay beliefs whereas the results discuss both prompted and unprompted ones. For measuring lay beliefs, unprompted questions may be considered more appropriate. As for the prompted questions, the respondent may not be holding the belief but may choose one from the responses which may be biased(eg - social desirability bias) 337 Table 4 has a hastag – the footnote is missing 391 “Adapting existing interventions to include additional messaging will be an efficient and cost-effective approach to addressing low breast cancer risk factor awareness.” - This statement should be supported with appropriate evidence. 406-407 - “Of concern is the finding that many women in rural SA and urban and rural Uganda, did not identify lack of screening as a risk factor for cervical cancer ??” Considering a lack of screening as a risk factor for cervical cancer may not be appropriate as most other risk factors are related to the occurrence of cervical cancer while lack of screening may be a risk factor for delayed presentation of cervical cancer but technically it may be in-appropriate to consider it as a risk factor for occurrence of cervical cancer. 408 -”Poor screening awareness has also been reported elsewhere in Africa [28,29]. Cervical cancer screening coverage is suboptimal in SSA [30]. In SA, after 409 more than 15 years of a public sector screening program national screening coverage is at 65%, with some provinces having coverage rates as low as 46% [26,31]. In Uganda, there is no national population based cervical cancer screening program. Limited opportunistic screening takes place at national referral and regional referral hospitals when women attend for other reasons. Studies have reported low self-reported cervical screening uptake among community women in different parts of Uganda, ranging from 4.8% to 7.0% [32,33].” - The description of status of screening services in the two countries may be reduced significantly or removed completely, it is not enriching the discussion in the context of the study's findings. Similarly the discussion on HIV and HPV vaccine needs to be reduced significantly. 512 – The way in which the questions related to recognition of breast and cervical cancer symptoms were asked appear to be a major limitation of the study. While the methodology described in the study talks about the measurement of awareness of breast and cervical cancer symptoms as one of the major objectives, the way in which the question has been framed “Can you tell me if you think the following could be signs of something serious or that something is wrong, such as breast cancer?” the interpretation and responses would not have been as per the objective. This significantly reduces the confidence of the reader on the findings on the awareness of the symptoms. An interaction with the data collection team to understand how the question was interpreted by most of the respondents may help in addressing this issue. 534 – The conclusion should not be generalised for the entire countries unless the authors are extremely confident of the studied sample being representative of the entire countries. Also a few examples of how exactly can the findings can inform targeted interventions can be of great help to make the description more specific. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #3: Yes: Abhishek Shankar Reviewer #4: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Mapping awareness of breast and cervical cancer risk factors, symptoms and lay beliefs in Uganda and South Africa PONE-D-20-06115R2 Dear Dr. Moodley, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Joel Msafiri Francis, MD, MS, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #3: Dear Authors Thank you working on the comments and making it appropriate for publication. We appreciate your efforts. With good wishes Abhishek ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #3: Yes: Abhishek Shankar |
| Formally Accepted |
|
PONE-D-20-06115R2 Mapping awareness of breast and cervical cancer risk factors, symptoms and lay beliefs in Uganda and South Africa Dear Dr. Moodley: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Joel Msafiri Francis Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .